Physician profile
Genevieve L Everett
NPI 1275736415
$15,668.44
in general payments reported to CMS, 2019-2025
25 companies · $1,946 in 2025
The $1,946 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,722 · 2020: $963 · 2021: $2,034 · 2022: $2,003 · 2023: $2,110 · 2024: $3,891 · 2025: $1,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,456 · Travel and Lodging: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,456.03 |
| Travel and Lodging | $1,491.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,664.21 | 2019-2025 | Emblem Mri S-Icd, Ingevity Mri, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $992.81 | 2019-2025 | Lifevest |
| Medtronic, INC. | $767.79 | 2021-2024 | Arctic Front Advance, Cobalt Dr Mri Surescan, Na |
| Boehringer Ingelheim Pharmaceuticals, INC. | $341.81 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $254.30 | 2019-2025 | |
| Amgen INC. | $215.26 | 2019-2024 | Repatha |
| Abbott Laboratories | $191.80 | 2019-2024 | Aveir |
| Janssen Pharmaceuticals, INC | $189.60 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $185.26 | 2022-2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $147.36 | 2019-2020 | |
| Inari Medical, INC. | $126.34 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $122.87 | 2019-2020 | |
| Medtronic Vascular, INC. | $111.72 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $84.83 | 2024-2025 | Uptravi, Opsynvi |
| Sanofi-Aventis U.S. LLC | $50.64 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiofocus, INC. | $36.43 | 2019 | |
| Atricure, INC. | $34.07 | 2019-2020 | |
| Cardiva Medical, INC. | $31.25 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lundbeck LLC | $27.38 | 2019 | |
| Irhythm Technologies, INC. | $17.25 | 2019 | |
| Portola Pharmaceuticals, LLC | $16.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.51 | 2019 | |
| Impulse Dynamics (USA) INC. | $15.47 | 2019 | |
| Cook Medical LLC | $14.59 | 2019 | |
| Amarin Pharma, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genevieve Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.